BPPV, history of gout associated with Ménière's disease

Published Date: 02 Mar 2023

According to a study published online Dec. 26 in the Journal of Clinical Medicine, a history of gout is associated with an increased risk of benign paroxysmal positional vertigo (BPPV) and Ménière's disease.

Read Full News

Latest News

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Barrett’s Esophagus Guidance Emphasizes Risk Stratification

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Latest News

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

News All Time

Alcohol-Related Chronic Pancreatitis Linked to Better Outcomes Than Non-Alcohol-Related Disease

Alcohol-Related Chronic Pancreatitis Linked to Better Outcomes Than Non-Alcohol-Related Disease

EBX-102-02 Shows Benefit for IBS-C and IBS-D in Phase 2a TrIuMPH Trial

EBX-102-02 Shows Benefit for IBS-C and IBS-D in Phase 2a TrIuMPH Trial

Q4 2025 Recap: Gastroenterology News and Updates

Q4 2025 Recap: Gastroenterology News and Updates

5 Gastroenterology Headlines You Missed in December 2025

5 Gastroenterology Headlines You Missed in December 2025

Young Adults With IBD Face Greater Healthcare Access Challenges, Financial Burdens

Young Adults With IBD Face Greater Healthcare Access Challenges, Financial Burdens

Gastroenterology in 2025: Year in Review

Gastroenterology in 2025: Year in Review

Young Women With Ulcerative Colitis Face Higher Corticosteroid Exposure Risk

Young Women With Ulcerative Colitis Face Higher Corticosteroid Exposure Risk

Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible

Intensive Weight Loss Before Colorectal Cancer Surgery Safe, Feasible

Discussing Safety, Tolerability of Tenapanor in Pediatric IBS-C patients, with Thomas Wallach, MD Thomas Wallach, MD

Thomas Wallach, MD, discusses phase 3 safety data of tenapanor in pediatric patients with IBS-C, presented at the 2025 NASPGHAN Annual Meeting.

Predicting Teduglutide Treatment Response for Pediatric SBS-IF, With Valeria Cohran, MD

Predicting Teduglutide Treatment Response for Pediatric SBS-IF, With Valeria Cohran, MD

Microbiota Restoration Therapy: A New Era in C. difficile Management, With Paul Feuerstadt, MD Paul Feuerstadt, MD

FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.

H. pylori Geographical Prevalence and NASPGHAN/ESPGHAN Guidelines, With Silvana Bonilla, MD Silvana Bonilla, MD

Multicenter data presented by Silvana Bonilla, MD, at NASPGHAN 2025 highlight regional variation in pediatric H. pylori prevalence and support selective biopsy practices guided by clinical suspicion.

5 Gastroenterology Headlines You Missed in November 2025

5 Gastroenterology Headlines You Missed in November 2025

Geographic Disparities in GI Specialist Availability Suggest Limited Access to Care

Geographic Disparities in GI Specialist Availability Suggest Limited Access to Care

AI Tools Fall Short for Dietary Recommendations for Managing IBS

AI Tools Fall Short for Dietary Recommendations for Managing IBS

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

Recommended News For You

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

Recommended Articles For You

Colon cancer: Risk factors, warning signs and treatment options  

From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine  

The Power of Romiplostim in Treating Low Platelet Counts  

An Overview Of Serum Osmolality: What Is It And How Can It Help You? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

3.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

4.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

5.

Hemihedral resection not necessary for neuroendocrine surgery after appendicitis

1.

7 Subtle Signs of Leukemia: How to Spot the Symptoms Early

2.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

3.

The Link Between Being Overweight and Cancer

4.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

5.

The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

3.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

5.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot